ZD and dysregulation have been implicated in synaptic dysfunction and impaired learning and memory
These criteria include type 2 diabetes diagnosis, cardiovascular disease or equivalent risk factors, HbA1c levels, and metabolic markersnot weight status
Trends in Pharmacological Sciences , 39(3), 185-194
Semaglutide's mechanism of actionactivating GLP-1 receptors in the brain, pancreas, and gastrointestinal tractdepends on the medication reaching systemic circulation, not on the specific injection location
Here are the most common reasons people and their doctors decide the change makes sense: Have hit a weight loss plateau after several months on Tirzepatide Want a treatment that targets three hormone receptors rather than two Need stronger blood sugar management alongside weight control Are looking for a medication that may also boost energy expenditure Your current health status, treatment history, and personal goals all factor into whether switching from Tirzepatide to Retatrutide is the right move
